WA28118 Study of Tocilizumab in sJIA

• Research type

  Research Study

• Full title

  A Phase Ib open label, multi-centre study to investigate the pharmacokinetics, pharmacodynamics, and safety of Tocilizumab following subcutaneous administration in patients with systemic juvenile idiopathic arthritis

• IRAS ID

  130144

• Contact name

  Athimalaipet Ramanan

• Contact email

  athimalaipet.ramanan@UHBristol.nhs.uk

• Sponsor organisation

  F Hoffmann-La Roche Ltd

• Eudract number

  2012-003490-26

• REC name

  North West - Greater Manchester Central Research Ethics Committee

• REC reference

  13/NW/0321

• Date of REC Opinion

  14 Jun 2013

• REC opinion

  Further Information Favourable Opinion